Xometry, Inc. (NASDAQ:XMTR) is Vitruvian Partners LLP's 4th Largest Position

Key Points

• Vitruvian Partners LLP increased its stake in Xometry, Inc. by 25.7%, buying an additional 68,500 shares, which makes Xometry about 8.0% of its investment portfolio.
• Major hedge funds like Vanguard Group Inc. and Sylebra Capital LLC have also raised their positions in Xometry, indicating a growing interest among institutional investors.
• Xometry stock has a current consensus rating of "Moderate Buy" with an average target price of $35.78, supported by research reports from several financial institutions.

Vitruvian Partners LLP increased its holdings in shares of Xometry, Inc. (NASDAQ:XMTR - Free Report) by 25.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 334,785 shares of the company's stock after buying an additional 68,500 shares during the quarter. Xometry accounts for about 8.0% of Vitruvian Partners LLP's portfolio, making the stock its 4th largest position. Vitruvian Partners LLP owned approximately 0.67% of Xometry worth $8,343,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Summit Investment Advisors Inc. boosted its stake in shares of Xometry by 8.1% in the fourth quarter. Summit Investment Advisors Inc. now owns 4,447 shares of the company's stock worth $190,000 after buying an additional 333 shares during the last quarter. GAMMA Investing LLC boosted its stake in shares of Xometry by 160.1% in the first quarter. GAMMA Investing LLC now owns 1,004 shares of the company's stock worth $25,000 after acquiring an additional 618 shares during the last quarter. State of Wyoming boosted its stake in shares of Xometry by 8.2% in the fourth quarter. State of Wyoming now owns 8,876 shares of the company's stock worth $379,000 after acquiring an additional 676 shares during the last quarter. Comerica Bank boosted its stake in shares of Xometry by 195.1% in the fourth quarter. Comerica Bank now owns 1,133 shares of the company's stock worth $48,000 after acquiring an additional 749 shares during the last quarter. Finally, Canada Pension Plan Investment Board acquired a new stake in shares of Xometry in the fourth quarter worth approximately $38,000. 97.31% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on XMTR. The Goldman Sachs Group lifted their price target on Xometry from $30.00 to $33.00 and gave the stock a "buy" rating in a research note on Thursday, May 8th. UBS Group lifted their price objective on Xometry from $33.00 to $35.00 and gave the stock a "neutral" rating in a research report on Wednesday, May 7th. Royal Bank Of Canada lifted their price objective on Xometry from $32.00 to $36.00 and gave the stock a "sector perform" rating in a research report on Wednesday, May 7th. JPMorgan Chase & Co. lifted their price objective on Xometry from $36.00 to $38.00 and gave the stock an "overweight" rating in a research report on Tuesday, June 3rd. Finally, Cantor Fitzgerald lifted their price objective on Xometry from $20.00 to $21.00 and gave the stock an "underweight" rating in a research report on Wednesday, May 7th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $35.78.

Insider Buying and Selling at Xometry

In other Xometry news, CEO Randolph Altschuler sold 9,332 shares of the stock in a transaction on Wednesday, July 2nd. The stock was sold at an average price of $32.39, for a total value of $302,263.48. Following the completion of the transaction, the chief executive officer owned 319,602 shares in the company, valued at approximately $10,351,908.78. This represents a 2.84% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Emily Rollins sold 10,041 shares of the stock in a transaction on Friday, May 9th. The stock was sold at an average price of $30.70, for a total value of $308,258.70. Following the completion of the transaction, the director owned 11,105 shares of the company's stock, valued at $340,923.50. The trade was a 47.48% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 9.66% of the company's stock.

Xometry Stock Performance

Xometry stock traded down $1.27 during mid-day trading on Friday, reaching $31.07. 594,086 shares of the company were exchanged, compared to its average volume of 585,375. The company has a debt-to-equity ratio of 0.91, a quick ratio of 3.70 and a current ratio of 3.74. The firm's 50-day simple moving average is $33.44 and its two-hundred day simple moving average is $30.38. The firm has a market cap of $1.57 billion, a PE ratio of -31.38 and a beta of 0.83. Xometry, Inc. has a twelve month low of $11.33 and a twelve month high of $45.33.

Xometry Company Profile

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.